A novel signature of combing cuproptosis- with ferroptosis-related genes for prediction of prognosis, immunologic therapy responses and drug sensitivity in hepatocellular carcinoma

BACKGROUND: Our study aimed to construct a novel signature (CRFs) of combing cuproptosis-related genes with ferroptosis-related genes for the prediction of the prognosis, responses of immunological therapy, and drug sensitivity of hepatocellular carcinoma (HCC) patients. METHODS: The RNA sequencing...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Chuanbing, Zhang, Zhengle, Jing, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562991/
https://www.ncbi.nlm.nih.gov/pubmed/36249031
http://dx.doi.org/10.3389/fonc.2022.1000993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562991/
https://www.ncbi.nlm.nih.gov/pubmed/36249031
http://dx.doi.org/10.3389/fonc.2022.1000993

Ejemplares similares